Effect of Lowering IOP in Glaucoma Suspects With HM
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
Currently, whether and when intraocular pressure (IOP) lowering medication should be used in
glaucoma suspects with high myopia (HM) is still a dilemma. Randomized trials are required to
evaluate whether IOP lowering influences the incidence of glaucoma suspect progression in HM
eyes.